Mydriasert 0.28mg/5.4mg Ophthalmic Insert: Company-led recall
Thea Pharmaceuticals are recalling a specific batch of Mydriasert 0.28mg/5.4mg Ophthalmic Insert as it is labelled as being for the French market, rather than the UK market.
Product information
CLDA number
CLDA (18)A/07
MDR number
MDR 15-09/18
Company name
Thea Pharmaceuticals
Product description
Mydriasert 0.28mg/5.4mg Ophthalmic Insert PL 20162/0011
Batch number/expiry
| Batch Number | Expiry Date |
| B208811B49C | July 2019 |
Brief description of the problem
The above batch, which has inadvertently been distributed in the UK, is being recalled because it is labelled for the French market.
Company contact for general enquiries:
Christine Purslow
Tel: 07889 535 661
Email chris.purslow@theapharm.com
Company contact for further information enquiries:
Medical Information line: 0345 521 1290
Updates to this page
Published 11 September 2018